Versono Medical is an early stage Irish MedTech company located in Galway, a global centre for excellence in medical technologies. The company collaborates with clinicians and research institutions across the world.
The company’s focus is on developing and commercialising a new technology platform for endovascular surgery that will focus initially on patients with Critical limb ischemia CLI, the most severe and advanced clinical manifestation of Peripheral Arterial Disease PAD. Versono’s mission is to enable endovascular treatment of Complex Chronic Lesions to alleviate pain, save limbs and save lives in order to address poor patient outcomes, high amputation and high mortality rates associated with CLI.
The technology targets severe occlusions in CLI patients, which presents one of the most challenging unmet needs in peripheral endovascular surgery. Versono’s product is designed to efficiently revascularize the lesion and present an avenue for subsequent therapeutic interventions to improve patient outcomes.